Clinical trial
Impact of MEditerranean Diet, Inflammation and Microbiome on Plaque Vulnerability and Microvascular Dysfunction After an Acute Coronary Syndrome. A Randomized, Controlled, Mechanistic Clinical Trial.
NCT03842319 is registered in ClinicalTrials.gov with Consorcio Centro de Investigación Biomédica en Red (CIBER) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of MEditerranean Diet, Inflammation and Microbiome on Plaque Vulnerability and Microvascular Dysfunction After an Acute Coronary Syndrome. A Randomized, Controlled, Mechanistic Clinical Trial.
- Lead sponsor
- Consorcio Centro de Investigación Biomédica en Red (CIBER)
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 14, 2019
- Completion date
- August 2, 2022
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.